Page last updated: 2024-08-21

6-aminonicotinamide and Bladder Cancer

6-aminonicotinamide has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, A; Chen, X; Fu, G; Jin, B; Pan, H; Wang, Y; Xu, Z; Zhu, Z	1

Other Studies

1 other study(ies) available for 6-aminonicotinamide and Bladder Cancer

Article	Year
Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro. International journal of oncology, 2018, Volume: 53, Issue:4 Topics: 6-Aminonicotinamide; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Female; Gene Knockdown Techniques; Glucosephosphate Dehydrogenase; HEK293 Cells; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Survival Rate; Urinary Bladder; Urinary Bladder Neoplasms	2018

Article

Year

Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.

International journal of oncology, 2018, Volume: 53, Issue:4

Topics: 6-Aminonicotinamide; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Female; Gene Knockdown Techniques; Glucosephosphate Dehydrogenase; HEK293 Cells; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Survival Rate; Urinary Bladder; Urinary Bladder Neoplasms

2018